HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.

AbstractBACKGROUND AND AIM:
Irritable bowel syndrome (IBS) is a harassing condition leading to the impairment of the quality of life. Adjustment to illness is an important personality factor able to influence the outcome. We looked for the psychological adjustment to illness in IBS. We also investigated the effect of trimebutine, a drug frequently used in IBS, on symptoms and psychosocial adjustment to illness in IBS.
METHODS:
A prospective randomized controlled trial including 50 consecutive patients with irritable bowel syndrome. They received either trimebutine 100 mg t.i.d (n=25, 11M/14F, aged 44+/-12 years) or placebo t.i.d. (n=25, 12M/13F, 48+/-10 years) for 2 weeks. Seven digestive symptoms were evaluated on a 0-16 scale, as well as the patient's satisfaction (scale 1-10) and the physician's satisfaction (scale 0-4) with the therapy. The psychosocial adjustment to illness was assessed by the PAIS-SR scale (self-report).
RESULTS:
Trimebutine increased significantly the following items of the PAIS-SR questionnaire: vocational environment, domestic environment, sexual relationships, extended family relationships, social environment but not health care orientation and psychological distress. Symptom score (mean+/-SD) for pain was reduced from 13.1+/-4.0 to 2.7+/-1.1, p<0.0001 by trimebutine and from 12.5+/-3.6 to 7.7+/-2.5, p<0.05 by placebo. Bloating score was decreased by trimebutine from 10.3+/-3.6 to 2.6+/-1.2 (p<0.0001) and not by placebo (from 10.5+/-4.5 to 8.8+/-3.6 N.S.). Nausea, emesis, anorexia, diarrhea and constipation were also improved by trimebutine. Placebo improved anorexia and tended to improve nausea. Patient' s satisfaction score was 8.1+/-1.1 with trimebutine and 5.2+/-3.5 with placebo (p<0.01). Physician's satisfaction score was 3.0+/-0.7 with trimebutine and 2.2+/-1.1 with placebo (p<0.02).
CONCLUSIONS:
Trimebutine improved symptoms and psychological adjustment to illness in irritable bowel syndrome in comparison with placebo.
AuthorsD L Dumitraşcu, Mihaela Stănculete
JournalRomanian journal of internal medicine = Revue roumaine de medecine interne (Rom J Intern Med) Vol. 44 Issue 3 Pg. 273-80 ( 2006) ISSN: 1220-4749 [Print] Germany
PMID18386606 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Gastrointestinal Agents
  • Trimebutine
Topics
  • Adaptation, Psychological
  • Adult
  • Female
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Irritable Bowel Syndrome (complications, drug therapy, psychology)
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Prospective Studies
  • Social Adjustment
  • Treatment Outcome
  • Trimebutine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: